Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.450
-0.010 (-0.68%)
At close: Nov 5, 2025, 4:00 PM EST
1.510
+0.060 (4.14%)
After-hours: Nov 5, 2025, 7:59 PM EST

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
272650294218747131
Upgrade
Market Cap Growth
-59.33%120.90%35.19%-70.86%471.21%-
Upgrade
Enterprise Value
3177092519754939
Upgrade
Last Close Price
1.455.052.842.117.2510.17
Upgrade
PS Ratio
236.46--139.03591.2787.68
Upgrade
PB Ratio
55.95-12.3421.721.866.111.85
Upgrade
P/TBV Ratio
67.01-21.721.866.11-
Upgrade
EV/Sales Ratio
388.11--61.82434.3125.88
Upgrade
Debt / Equity Ratio
20.72-1.544.290.430.420.41
Upgrade
Asset Turnover
0.01--0.010.010.01
Upgrade
Quick Ratio
1.822.254.367.7620.423.57
Upgrade
Current Ratio
2.452.404.517.8820.763.69
Upgrade
Return on Equity (ROE)
---169.81%-10.01%-27.46%-65.58%
Upgrade
Return on Assets (ROA)
-50.18%-53.74%-36.44%-21.54%-25.81%-29.32%
Upgrade
Return on Capital (ROIC)
-100.22%-142.57%-50.66%-31.01%-37.20%-31.18%
Upgrade
Earnings Yield
-21.63%-22.88%-37.66%-5.50%-3.55%-50.88%
Upgrade
FCF Yield
-39.14%-15.34%-25.70%-33.17%-10.90%-42.75%
Upgrade
Buyback Yield / Dilution
-22.81%-14.56%-0.36%-157.82%-593.25%71.34%
Upgrade
Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q